Expression of HYAL2 mRNA, hyaluronan and hyaluronidase in B-cell non-hodgkin lymphoma: Relationship with tumor aggressiveness

International Journal of Cancer

Volumn 113, Issue 2, 2005, Pages 207-212

  Bertrand, Philippe ^a   Courel, Marie Noëlle ^a   Maingonnat, Catherine ^a   Jardin, Fabrice ^a   Tilly, Hervé ^a   Bastard, Christian ^a  

^a CENTRE HENRI BECQUEREL   (France)

Author keywords

HYAL2; Hyaluronan; Hyaluronidase; Lymphoma

Indexed keywords

HYALURONIC ACID; HYALURONIDASE; HYALURONIDASE 1; HYALURONIDASE 2; MESSENGER RNA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; B CELL LYMPHOMA; CANCER INHIBITION; CHROMOSOME 3P; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; ZYMOGRAPHY;

CELL ADHESION MOLECULES; CHROMOSOMES, HUMAN, PAIR 3; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; LYMPHOMA, B-CELL; PROGNOSIS; RECEPTORS, VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 10344256152     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20562     Document Type: Article

References (44)

1. Chen WY, Abatangelo G. Functions of hyaluronan in wound repair. Wound Repair Regen 1999;7:79-89.
2. Toole BP. Hyaluronan in morphogenesis. Semin Cell Dev Biol 2001;12:79-87.
3. Bertrand P, Girard N, Duval C, D'Anjou J, Chauzy C, Menard JF, Delpech B. Increased hyaluronidase levels in breast tumor metastases. Int J Cancer 1997;73:327-31.
4. Bullard KM, Kim HR, Wheeler MA, Wilson CM, Neudauer CL, Simpson MA, McCarthy JB. Hyaluronan synthase-3 is upregulated in metastatic colon carcinoma cells and manipulation of expression alters matrix retention and cellular growth. Int J Cancer 2003;107:739-46.
5. Jojovic M, Delpech B, Prehm P, Schumacher U. Expression of hyaluronate and hyaluronate synthase in human primary tumours and their metastases in scid mice. Cancer Lett 2002;188:181-9.
6. Liu D, Pearlman E, Diaconu E, Guo K, Mori H, Haqqi T, Markowitz S, Willson J, Sy MS. Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proc Natl Acad Sci USA 1996;93:7832-7.
7. West DC, Hampson IN, Arnold F, Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science 1985;228:1324-6.
8. Zeng C, Toole BP, Kinney SD, Kuo JW, Stamenkovic I. Inhibition of tumor growth in vivo by hyaluronan oligomers. Int J Cancer 1998;77:396-401.
9. Ghatak S, Misra S, Toole BP. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J Biol Chem 2002;277:38013-20.
10. Delpech B, Laquerriere A, Maingonnat C, Bertrand P, Freger P. Hyaluronidase is more elevated in human brain metastases than in primary brain tumours. Anticancer Res 2002;22:2423-7.
11. Lokeshwar VB, Lokeshwar BL, Pham HT, Block NL. Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. Cancer Res 1996;56:651-7.
12. Lokeshwar VB, Soloway MS, Block NL. Secretion of bladder tumor-derived hyaluronidase activity by invasive bladder tumor cells. Cancer Lett 1998;131:21-7.
13. Ji L, Nishizaki M, Gao B, Burbee D, Kondo M, Kamibayashi C, Xu K, Yen N, Atkinson EN, Fang B, Lerman MI, Roth JA, et al. Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res 2002:62:2715-20.
14. Shuster S, Frost GI, Csoka AB, Formby B, Stern R. Hyaluronidase reduces human breast cancer xenografts in SCID mice. Int J Cancer 2002;102:192-7.
15. Jacobson A, Rahmanian M, Rubin K, Heldin P. Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumors. Int J Cancer 2002;102:212-9.
16. Csoka AB, Frost GI, Stern R. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol 2001;20:499-508.
17. Rai SK, Duh FM, Vigdorovich V, Danilkovitch-Miagkova A, Lerman MI, Miller AD. Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Proc Natl Acad Sci USA 2001;98:4443-8.
18. Stern R. Devising a pathway for hyaluronan catabolism: are we there yet? Glycobiology 2003;13:105R-115R.
19. Girard N, Maingonnat C, Bertrand P, Tilly H, Vannier JP, Delpech B. Human monocytes synthesize hyaluronidase. Br J Haematol 2002;119:199-203.
20. Jaffe ES, Harris NL, Stein H, Vardiman J. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyons: IARC Press, 2001.
21. Bieche I, Olivi M, Champeme MH, Vidaud D, Lidereau R, Vidaud M. Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer. Int J Cancer 1998;78:661-6.
22. Jardin F, Buchonnet G, Parmentier F, Contentin N, Lepretre S, Lenain P, Picquenot JM, Laberge S, Bertrand P, Stamatoullas A, D'Anjou J, Tilly H, et al. Follicle center lymphoma is associated with significantly elevated levels of BCL-6 expression among lymphoma subtypes, independent of chromosome 3q27 rearrangements. Leukemia 2002;16:2318-25.
23. Delpech B, Bertrand P, Maingonnat C, Girard N, Chauzy C. Enzyme-linked hyaluronectin: a unique reagent for hyaluronan assay and tissue location and for hyaluronidase activity detection. Anal Biochem 1995;229:35-41.
24. Fraser JR, Kimpton WG, Laurent TC, Cahill RN, Vakakis N. Uptake and degradation of hyaluronan in lymphatic tissue. Biochem J 1988; 256:153-8.
25. Armstrong SE, Bell DR. Relationship between lymph and tissue hyaluronan in skin and skeletal muscle. Am J Physiol Heart Circ Physiol 2002;283:H2485-94.
26. Pawlowski A, Haberman HF, Menon IA. The effects of hyalurodinase upon tumor formation in BALB/c mice painted with 7,12-dimethyl-benz-(a)anthracene. Int J Cancer 1979;23:105-9.
27. Yang Q, Yoshimura G, Mori I, Sakurai T, Kakudo K. Chromosome 3p and breast cancer. J Hum Genet 2002;47:453-9.
28. Lerman MI, Minna JD. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. Cancer Res 2000;60:6116-33.
29. Cigudosa JC, Parsa NZ, Louie DC, Filippa DA, Jhanwar SC, Johansson B, Mitelman F, Chaganti RS. Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas. Genes Chromosomes Cancer 1999;25:123-33.
30. Mullegger J, Lepperdinger G. Degradation of hyaluronan by a Hyal2-type hyaluronidase affects pattern formation of vitelline vessels during embryogenesis of Xenopus laevis. Mech Dev 2002;111:25-35.
31. Fiszer-Szafarz B, Litynska A, Zou L. Human hyaluronidases: electrophoretic multiple forms in somatic tissues and body fluids - evidence for conserved hyaluronidase potential N-glycosylation sites in different mammalian species. J Biochem Biophys Methods 2000;45: 103-16.
32. Funamoto Y, Nagai M, Haba R, Kishida F, Kohno K, Kobayashi S. Hyaluronan synthesis by anaplastic large cell lymphoma with massive lymphomatous effusion: a case report. Acta Cytol 2002;46:864-8.
33. Kuwabara H, Yoneda M, Nagai M, Nishio H, Tasaka T, Susuki K, Mori H. High levels of hyaluronan production by a malignant lymphoma cell line with primary effusion lymphoma immunophenotype OHK. Br J Haematol 2003;120:1055-7.
34. Rodriguez J, McLaughlin P, Hagemeister FB, Fayad L, Rodriguez MA, Santiago M, Hess M, Romaguera J, Cabanillas F. Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features. Blood 1999;93:2202-7.
35. Martin AR, Weisenburger DD, Chan WC, Ruby EI, Anderson JR, Vose JM, Bierman PJ, Bast MA, Daley DT, Armitage JO. Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. Blood 1995;85:3671-8.
36. Thylen A, Hjerpe A, Martensson G. Hyaluronan content in pleural fluid as a prognostic factor in patients with malignant pleural mesothelioma. Cancer 2001;92:1224-30.
37. Ropponen K, Tammi M, Parkkinen J, Eskelinen M, Tammi R, Lipponen P, Agren U, Alhava E, Kosma VM. Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res 1998;58:342-7.
38. Pirinen R, Tammi R, Tammi M, Hirvikoski P, Parkkinen JJ, Johansson R, Bohm J, Hollmen S, Kosma VM. Prognostic value of hyaluronan expression in non-small-cell lung cancer: increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma. Int J Cancer 2001;95:12-7.
39. Bohm J, Niskanen L, Tammi R, Tammi M, Eskelinen M, Pirinen R, Hollmen S, Alhava E, Kosma VM. Hyaluronan expression in differentiated thyroid carcinoma. J Pathol 2002;196:180-5.
40. Drillenburg P, Pals ST. Cell adhesion receptors in lymphoma dissemination. Blood 2000;95:1900-10.
41. Sy MS, Guo YJ, Stamenkovic I. Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med 1991;174:859-66.
42. Hiltunen EL, Anttila M, Kultti A, Ropponen K, Penttinen J, Yliskoski M, Kuronen AT, Juhola M, Tammi R, Tammi M, Kosma VM. Elevated hyaluronan concentration without hyaluronidase activation in malignant epithelial ovarian tumors. Cancer Res 2002;62:6410-3.
43. Till KJ, Zuzel M, Cawley JC. The role of hyaluronan and interleukin 8 in the migration of chronic lymphocytic leukemia cells within lymphoreticular tissues. Cancer Res 1999;59:4419-26.
44. Xu XM, Chen Y, Chen J, Yang S, Gao F, Underhill CB, Creswell K, Zhang L. A peptide with three hyaluronan binding motifs inhibits tumor growth and induces apoptosis. Cancer Res 2003;63:5685-90.